NSE filing, NSE: VAISHALI. Summary written from the filing by ALFA Finder's alert engine.
Vaishali Pharma Ltd: key numbers
- Share price
- ₹6.51
- Market cap
- ₹87.88 Cr
- Revenue (annual)
- ₹108.8 Cr
- Net profit (annual)
- ₹4.16 Cr
- P/E (TTM)
- 19.8×Sector 47.2×
- Promoter holding
- 31.61%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaishali Pharma Ltd
All →Vaishali Pharma Preferential Issue
NSE has approved the listing of 45,37,865 equity shares allotted on a preferential basis by Vaishali Pharma Ltd, effective from October 16, 2026.
Vaishali Pharma Annual General Meeting
Vaishali Pharma Limited concluded its 19th Annual General Meeting on September 24, 2026, via video conferencing, transacting routine ordinary business matters.
Vaishali Pharma Capital Structure Change
Vaishali Pharma Ltd received listing approval from NSE for 45,37,865 equity shares issued on a preferential basis, subject to depository confirmation.
Vaishali Pharma Annual General Meeting
Vaishali Pharma Limited will hold its 19th Annual General Meeting on September 24, 2026, through video conferencing to transact ordinary business.
Vaishali Pharma Management Change
Vaishali Pharma Limited announced the resignation of Mr. Bhaveshkumar Popatlal Upadhyay from the position of Non-Executive Independent Director, effective August 14, 2026.
Vaishali Pharma Q1 FY27 Results: Net Profit ₹1.5 Cr, Up 15.4% YoY
Vaishali Pharma Ltd reported revenue from operations of ₹22.9 Cr (-3.4% YoY) and net profit of ₹1.5 Cr (+15.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr · +15.4% YoY
Other board meeting date announcements
All →Mangalam Industrial Finance Board Meeting Date
Mangalam Industrial Finance scheduled a board meeting for November 6, 2026. It will consider unaudited Q2 and H1 FY27 standalone results.
Olympic Cards Board Meeting Date
Olympic Cards schedules a board meeting on 12 November 2026 to consider unaudited quarterly results. The trading window stays closed until results are declared.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.
National General Industries Board Meeting Date
National General Industries will hold a board meeting on November 10, 2026 to consider unaudited quarterly results. Trading window stays closed until November 16, 2026.
Vision Cinemas Board Meeting Date
Vision Cinemas Limited has intimated a board meeting on 10 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after results declaration.